Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

  • There is currently no data for INDV

Indivior News

UPDATE: Indivior notes robust results for treatment in fentanyl trial
28 Jan 2022

UPDATE: Indivior notes robust results for treatment in fentanyl trial

UPDATE: Indivior notes robust results for treatment in fentanyl trial

CORRECT: Indivior notes results for painkiller in fentanyl trial
28 Jan 2022

CORRECT: Indivior notes results for painkiller in fentanyl trial

CORRECT: Indivior notes results for painkiller in fentanyl trial

Indivior's painkiller demonstrates positive interaction with fentanyl
28 Jan 2022

Indivior's painkiller demonstrates positive interaction with fentanyl

Indivior's painkiller demonstrates positive interaction with fentanyl

Indivior welcomes results from buprenorphine-fentanyl interaction study
28 Jan 2022

Indivior welcomes results from buprenorphine-fentanyl interaction study

(Sharecast News) - Pharmaceutical company Indivior hailed the results of a study aimed at assessing the ability of its buprenorphine asset to reduce r...

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair
19 Nov 2021

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data
10 Nov 2021

LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data

LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data

IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million
10 Nov 2021

IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million

IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million

Indivior slumps as Scopia Capital sells 20m shares
10 Nov 2021

Indivior slumps as Scopia Capital sells 20m shares

(Sharecast News) - Indivior was under the cosh on Wednesday after US alternative asset management firm Scopia Capital sold 20m shares in the opioid ad...